PatoGen Overview

  • Year Founded
  • 2005

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 60

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 2

PatoGen General Information

Description

Provider of laboratory and biotechnology research services dedicated to the detection of fish pathogens. The company develops and sells genetic engineering analyzers for the aquaculture industry to prevent infection and disease for its customers in Norway and Scotland, thereby offering expertise and quality data to generate sustainable growth of seafood production.

Contact Information

Website
www.patogen.no
Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Primary Industry
Other Commercial Services
Other Industries
Other Pharmaceuticals and Biotechnology
Corporate Office
  • Rasmus Rønnebergs Gate 21
  • 6002 Ålesund
  • Norway
+47 70 00 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

PatoGen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PatoGen‘s full profile, request access.

Request a free trial

PatoGen Patents

PatoGen Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3185583-A1 Piscine orthoreovirus virulence markers Pending 14-Jul-2020 00000000
EP-4182483-A1 Piscine orthoreovirus virulence markers Pending 14-Jul-2020 00000000
CA-3162676-A1 Method for detecting hydrogen peroxide resistance in crustaceans Pending 02-Jan-2020 0000000000
EP-4085155-A1 Method for detecting hydrogen peroxide resistance in crustaceans Pending 02-Jan-2020 0000000000
EP-3918095-A1 Piscine orthoreovirus virulence markers Pending 30-Jan-2019 C12Q1/701
To view PatoGen’s complete patent history, request access »

PatoGen Executive Team (11)

Name Title Board Seat Contact Info
Jørn Ulheim Chief Executive Officer
Kristoffer Stenstad Chief Financial Officer
Noralf Gamlem Chief Digital Officer
Birgit Myklebust Chief Laboratory Officer
Line Olaussen Chief Quality and Project Officer
You’re viewing 5 of 11 executive team members. Get the full list »

PatoGen Board Members (6)

Name Representing Role Since
0å0000 00000000 Self Chairman of the Board 000 0000
You’re viewing 1 of 6 board members. Get the full list »

PatoGen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

PatoGen Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore PatoGen‘s full profile, request access.

Request a free trial

PatoGen Subsidiaries (1)

Company Name Industry Location Founded
Patogen Nord Other Commercial Services Bodoe, Norway 0000
To view PatoGen’s complete subsidiaries history, request access »

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »